Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1
Journal of Molecular Histology · 2025
DOI: 10.1007/s10735-024-10326-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Histology, 2025. Verfasst von Dina H Merzeban und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Departments of Medical Physiology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. dhm00@fayoum.edu.eg. Hauptthemen laut MEDLINE: Liraglutide, Naltrexone, Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Traditional antidiabetic treatments often carry the risk of beta-cell exhaustion, highlighting the need for therapies that promote beta-cell regeneration. This study investigates the comparative effects of Liraglutide, naltrexone/bupropion (NTX + BUP), and caloric restriction on metabolic control and beta-cell regeneration in a rat model of obese type 2 diabetes. Fifty male albino rats were randomized into five groups: normal control, diabetic control, diabetic + caloric restriction (50%), diabetic + NTX + BUP (4 mg/45 mg /kg/day orally), and diabetic + liraglutide (0.3 mg/kg/day, S.C). Body weight, BMI, serum glucose, insulin, lipid profile, atherogenic indices, beta-arrestin-1 levels, pancreatic histopathology, and immunohistochemical staining for insulin and Ki67 were assessed. All interventions significantly improved body weight, BMI, glycemic control, lipid profiles (except HDL), and atherogenic indices compared to the diabetic control group. NTX + BUP and caloric restriction resulted in greater weight loss compared to liraglutide. Of note, liraglutide significantly decreased β-arrestin-1 levels compared to both NTX + BUP and caloric restriction. Furthermore, liraglutide and caloric restriction significantly increased anti-insulin antibodies and Ki67 indicating beta-cell regeneration, while NTX + BUP showed insignificant effects. Thus we can conclude that, while NTX + BUP demonstrates efficacy in improving metabolic parameters in obese type 2 diabetic rats, it shows limitations in promoting beta-cell regeneration compared to liraglutide and caloric restriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Departments of Medical Physiology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. dhm00@fayoum.edu.eg.
- The Departments of Medical Physiology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- The Departments of Anatomical Pathology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- The Departments of Histology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- The Departments of Biochemistry and Molecular Biology, Fayoum University, Fayoum, Egypt.
- The Departments of Pharmacology and Toxicology, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt.
Zitieren
APA
Merzeban, D. H., El Amin Ali, A. M., Hammad, R. O., Elmahdi, M. H., Sofi, M. A., Mahmoud, R. H., Metwally, S. M., & El Ebiary, A. M. (2025). Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10326-x
Vancouver
Merzeban DH, El Amin Ali AM, Hammad RO, Elmahdi MH, Sofi MA, Mahmoud RH, et al. Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1. Journal of Molecular Histology. 2025. doi:10.1007/s10735-024-10326-x
BibTeX
@article{Merzeban2025,
author = {Merzeban, Dina H and El Amin Ali, Amani M and Hammad, Reem O and Elmahdi, Mohamed H and Sofi, Marwa A and Mahmoud, Rania H and Metwally, Sayed M and El Ebiary, Ahmed M},
title = {Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1},
journal = {Journal of Molecular Histology},
year = {2025},
doi = {10.1007/s10735-024-10326-x}
}
EUVIMED